α4β1- and α6β1-integrins are functional receptors for midkine, a heparin-binding growth factor
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Midkine is a heparin-binding growth factor that promotes the growth, survival, migration and differentiation of various target cells. So far, receptor-type protein tyrosine phosphatase ζ, low-density-lipoprotein-receptor-related protein and anaplastic lymphoma kinase have been identified as receptors for midkine. We found β1 integrin in midkine-binding proteins from 13-day-old mouse embryos. β1-Integrin bound to a midkine-agarose column and was eluted mostly with EDTA. Further study revealed that the α-subunits capable of binding to midkine were α4 and α6. Purified α4β1- and α6β1-integrins bound midkine. Anti-α4 antibody inhibited the midkine-dependent migration of osteoblastic cells, and anti-α6 antibody inhibited the midkine-dependent neurite outgrowth of embryonic neurons. After midkine treatment, tyrosine phosphorylation of paxillin, an integrin-associated molecule, was transiently increased in osteoblastic cells. Therefore, we concluded that α4β1- and α6β1-integrins are functional receptors for midkine. We observed that the low-density-lipoprotein-receptor-related-protein-6 ectodomain was immunoprecipitated with α6β1-integrin and α4β1-integrin. The low-density-lipoprotein-receptor-related-protein-6 ectodomain was also immunoprecipitated with receptor-type protein tyrosine phosphatase ζ. α4β1- and α6β1-Integrins are expected to co-operate with other midkine receptors, possibly in a multimolecular complex that contains other midkine receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Role of integrins in regulating epidermal adhesion, growth and differentiation
Watt, F. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf399 · Cited by 647
Lipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457 · cited 1×
“They play key roles in morphogenesis, inflammation and tumor invasion (Hood and Cheresh, 2002; Watt, 2002; Bokel and Brown, 2002; Brakebusch et al., 2002).”
BackgroundReelin-induced tryosine phosphorylation of Disabled 1 during neuronal positioning
Howell, B. W., Herrick, T. M., & Cooper, J. A. (1999) · Genes & Development · doi:10.1101/gad.13.6.643 · Cited by 411
Proteins of the CNR Family Are Multiple Receptors for Reelin
Senzaki, K., Ogawa, M., & Yagi, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81552-4 · Cited by 272
Kinnunen, T., Raulo, E., Nolo, R., Maccarana, M., Lindahl, U., & Rauvala, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.2243 · Cited by 127 · cited 3×
“Integrins are heterodimeric membrane glycoproteins involved in cell-matrix and cell-cell interactions (Giancotti and Ruoslahti, 1999; Hynes, 2002; Kleiman and Mosher, 2002).”
Background
Cited by
Anaplastic lymphoma kinase: signalling in development and disease
Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B. (2009) · Biochemical Journal · doi:10.1042/bj20090387 · Cited by 423
Collateral circulation: Past and present
Schaper, W. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-008-0760-x · Cited by 388
Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
Filippou, P. S., Karagiannis, G. S., & Constantinidou, A. (2020) · Oncogene · doi:10.1038/s41388-019-1124-8 · Cited by 331
Pleiotrophin: Activity and mechanism
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2020.02.003 · Cited by 98
Herradón, G., & Pérez‐García, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12312 · Cited by 88
Metadata
- Authors
- Muramatsu, H., Zou, P., Suzuki, H., Oda, Y., Chen, G.-Y., Sakaguchi, N., Sakuma, S., Maeda, N., Noda, M., Takada, Y., & Muramatsu, T.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2004-10-15
- Volume
- 117
- Issue
- 22
- Pages
- 5405-5415
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W145628542
- Cited by
- 128
- References
- 6
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.